Hao Gao

Founded in 1998, Sichuan Qianyuan Traditional Chinese Medicine Pieces Co., Ltd. is a company that manufactures and distributes herbal medicine. Part of Shanxi C & Y Pharmaceutical Group Co., Ltd., the company is based in Guanghan, China. Sichuan Qianyuan Traditional Chinese Medicine Pieces Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. on September 03, 2021 for $0.69 million.

Shenzhen Juchao Rongkun Investment Management Co., Ltd. engages in the provision of investment management, investment consulting, and equity investment. The company was founded on July 1, 2014 and is headquartered in Shenzhen, China.

Shenzhen Sunleader Electronic Group Co. Ltd. is a company based in Shenzhen, China that engages in the distribution of automobile and property management. The Chinese company was founded in 1993 and the CEO is Qi Xu.

Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Hangzhou, China. Hangzhou Aoyi Pollen Pharmaceutical Co. was acquired by Hangzhou Baoling Group Co. Ltd. on February 27, 2015 for $15.26 million. Xue Min Zuo has been the CEO of the Chinese company since 2013.

Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong.

CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018.

Shenzhen Zhiliu Technology Co. Ltd. is a cloud-native microservice gateway provider based on Apache APISIX. The company is based in Shenzhen, China. The Chinese company offers products and solutions for microservices, real-time traffic processing, API gateway, Kubernetes Ingress Controller, and Service Mesh. Its enterprise-level products, Apache APISIX and API7, are used by hundreds of companies globally, including those in finance, internet, manufacturing, retail, and telecommunications industries. The company was founded in 2019 by Yuansheng Wang and Ming Wen, with Ming Wen serving as the CEO since 2019.

Part of Shanxi C & Y Pharmaceutical Group Co., Ltd., Suzhou Dmd biomed Co., Ltd. is a company that provides fluorescence in situ hybridization molecular diagnostic test kit technology development and technical consulting and services. The company is based in Suzhou, China. The Chinese company was founded in 2009. The CEO is Wei Jiang.

Part of Shanxi C & Y Pharmaceutical Group Co., Ltd., Hangzhou Enshi Gene Technology Co., Ltd. is a company that engages in the research and development of human gene purification & preservation technology. Hangzhou Enshi Gene Technology Co., Ltd. is based in Hangzhou, China. Hangzhou Enshi Gene Technology Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. on December 26, 2014 for $16.29 million. The Chinese company was founded in 2008. Xue Min Zuo has been the CEO of the company since 2014.

Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Zhejiang Hailisheng Pharmaceutical Co., Ltd. is a pharmaceutical company based in Zhoushan, CN. Zhejiang Hailisheng Pharmaceutical Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. from Zhoushan Yuantai Foodstuff Co., Ltd. on March 27, 2012 for $23.83 million. Zhejiang Hailisheng Pharmaceutical Co. manufactures and distributes pharmaceutical products. Xue Min Zuo has been the CEO of the Chinese company since 2014.